Nurix Therapeutics Inc.

NASDAQ: NRIX · Real-Time Price · USD
10.57
0.01 (0.09%)
At close: Aug 15, 2025, 3:59 PM
11.00
4.07%
After-hours: Aug 15, 2025, 05:17 PM EDT

Nurix Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is December - November.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Nov 30, 2024 Nov 30, 2023 Nov 30, 2022 Nov 30, 2021
Cash & Equivalents
110M 54.63M 64.47M 80.51M
Short-Term Investments
499.59M 233.28M 244.67M 215.21M
Long-Term Investments
n/a 7.42M 63.88M 137.19M
Other Long-Term Assets
4.06M 4.72M 4.92M 3.12M
Receivables
1.5M n/a n/a 6.2M
Inventory
n/a n/a -1.1M n/a
Other Current Assets
8.3M 7.59M 9.31M 1.1M
Total Current Assets
619.39M 295.5M 318.45M 311.12M
Property-Plant & Equipment
45.9M 47.95M 29.51M 25.34M
Goodwill & Intangibles
n/a n/a -3.3M -3.33M
Total Long-Term Assets
49.96M 60.09M 98.31M 165.65M
Total Assets
669.34M 355.6M 416.76M 476.77M
Account Payables
11.48M 6.4M 5.06M 6.65M
Deferred Revenue
38.36M 48.1M 37.63M 41.21M
Short-Term Debt
n/a 6.42M 5.53M 3.85M
Other Current Liabilities
36.76M 16.05M 9.14M 5.67M
Total Current Liabilities
95.85M 86.96M 70.66M 66.26M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
46.5M 68.15M 42.41M 68.21M
Total Liabilities
142.35M 155.1M 113.06M 134.47M
Total Debt
28.3M 30.61M 11.96M 13.04M
Common Stock
76K 49K 47K 45K
Retained Earnings
-738.77M -545.2M -401.25M -220.89M
Comprehensive Income
150K -655K -4.32M -608K
Shareholders Equity
526.99M 200.49M 303.7M 342.3M
Total Investments
499.59M 240.7M 308.55M 352.4M